New Alzheimer’s Drug Debate: Does It Work or Doesn’t It?

It’s been a long time coming. After more than 20 years of waiting, the FDA finally approved a new drug for Alzheimer’s disease. There’s just one problem: Not everybody thinks the drug does what its maker, Biogen, says it does, or that it even should have been approved. Unlike Dr. Dale Bredesen’s ReCODE protocol, which identifies your disease subtype or combination of subtypes so an effective treatment protocol that works can be devised, this new drug, aducanumab (brand...

Read the Full Article for Free!

You can unsubscribe at any time and I guarantee the privacy of your email. View our privacy policy

Subscribe for FREE to the #1 Natural Health Newsletter or Login for Instant Access

Unlock censored health information that Google doesn't want you to read

Keep your privacy secure — we are one of the few websites that have banned all Google and Facebook scripts to help stop their surveillance capitalism

Get access to all of Dr. Mercola's health articles, E-books and special reports